The province is getting on board with a drug treatment that will be good news for people with Hepatitis C.
Epclusa, a drug for Hep C with a near 100 per cent cure rate, is now going to be covered by Alberta Health.
“It needs to cover everyone, it needs to be highly effective, and needs to have no or very limited side effects, and this drug really fits that bill.”
It’s the first, once-daily single tablet regiment, and has been around for a short time, but people who need it have been waiting for it.
“People who have Hepatitis C have heard of these drugs that are coming along and have been just waiting to get a hold of it,” Swain said, “because it does fulfill all the needs of the people who need to be treated.”
Up until now, Swain added, only a few private plans covered the drug.
“The broad population of Alberta, many of them who get their drug coverage through the Alberta government program, such as non-group Alberta Blue Cross, they couldn’t access this drug.”
In Alberta there are about 24,000 people living with chronic Hepatitis C. That number is above the national average.